Advisory Services Network’s Xeris Biopharma Holdings XERS Stock Holding History

Advisory Services Network’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,000	Closed	-$5.8K	–	4639
2026 Q1	$5.8K	Buy	+1,000	New	+$6.63K	﹤0.01%	3786
2025 Q4	–	Sell	-1,000	Closed	-$8.14K	–	4264
2025 Q3	$8.14K	Buy	+1,000	New	+$6.64K	﹤0.01%	3362
2021 Q3	–	Sell	-45	Closed	–	–	3248
2021 Q2	$0	Buy	+45	New	+$172	﹤0.01%	3654
2020 Q4	–	Sell	-315	Closed	-$2K	–	3754
2020 Q3	$2K	Buy	+315	New	+$1.26K	﹤0.01%	3211

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Advisory Services Network's XERS Position: Q2 2026 in Review

Advisory Services Network sold out of Xeris Biopharma Holdings (XERS) in Q2 2026, closing a stake of 1,000 shares — an estimated $5.8K sold.

Advisory Services Network first reported a position in XERS in Q3 2020 and held it in 4 quarters. The position peaked at $8.14K in Q3 2025. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

Advisory Services Network reported no remaining Xeris Biopharma Holdings position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 1,000 Xeris Biopharma Holdings shares in Q2 2026, an estimated $5.8K.
Advisory Services Network first reported a position in Xeris Biopharma Holdings in Q3 2020 and held it in 4 quarters.
Advisory Services Network's Xeris Biopharma Holdings position peaked at $8.14K in Q3 2025.
241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.